These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 10379634)

  • 1. The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients--assessment by spectral analysis of heart rate and blood pressure variability.
    Salo TM; Kantola I; Voipio-Pulkki LM; Pelttari L; Viikari JS
    Eur J Clin Pharmacol; 1999 May; 55(3):191-8. PubMed ID: 10379634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
    Pelttari LH; Hietanen EK; Salo TT; Kataja MJ; Kantola IM
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea.
    Kraiczi H; Hedner J; Peker Y; Grote L
    Am J Respir Crit Care Med; 2000 May; 161(5):1423-8. PubMed ID: 10806134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hypotensive drugs on the circadian blood pressure pattern in essential hypertension: a comparative study.
    Zakopoulos N; Stamatelopoulos S; Moulopoulos S
    Cardiovasc Drugs Ther; 1997 Dec; 11(6):795-9. PubMed ID: 9512875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of losartan and enalapril, alone or with a diuretic, on ambulatory blood pressure and cardiac performance in hypertension: a case-control study.
    Verdecchia P; Schillaci G; Reboldi GP; Sacchi N; Bruni B; Benemio G; Porcellati C
    Blood Press Monit; 2000 Jun; 5(3):187-93. PubMed ID: 10915233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.
    Ajayi AA; Sofowora GG; Adigun AQ; Asiyanbola B
    Ethn Dis; 2003; 13(1):71-9. PubMed ID: 12723015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function.
    Schiffrin EL; Park JB; Pu Q
    J Hypertens; 2002 Jan; 20(1):71-8. PubMed ID: 11791028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomic function and baroreflex sensitivity during angiotensin-converting enzyme inhibition or angiotensin II AT-1 receptor blockade in essential hypertensive patients.
    Guasti L; Petrozzino MR; Mainardi LT; Grimoldi P; Zanotta D; Garganico D; Diolisi A; Simoni C; Grandi AM; Gaudio G; Cerutti S; Venco A
    Acta Cardiol; 2001 Oct; 56(5):289-95. PubMed ID: 11712824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of the angiotensin II antagonist candesartan cilexetil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats.
    Wada T; Sanada T; Ojima M; Kanagawa R; Nishikawa K; Inada Y
    Hypertens Res; 1996 Dec; 19(4):247-54. PubMed ID: 8986455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of increased sympathetic vasomotor drive with shorter acting dihydropyridine calcium channel antagonists in human hypertension: a study using spectral analysis of RR interval and systolic arterial pressure variability.
    Lucini D; Mela GS; Malliani A; Pagani M
    J Cardiovasc Pharmacol; 1997 May; 29(5):676-83. PubMed ID: 9213212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine.
    Breithaupt-Grögler K; Ungethüm W; Meurer-Witt B; Belz GG
    Eur J Clin Pharmacol; 2001 Jul; 57(4):275-84. PubMed ID: 11549204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antihypertensive medication on hypertension in patients with sleep apnoea.
    Pelttari L; Rauhala E; Kantola I
    Blood Press Suppl; 1994; 2():88-91. PubMed ID: 8061854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension.
    Panfilov V; Morris AD; Donnelly R; Scemama M; Reid JL
    Br J Clin Pharmacol; 1995 Dec; 40(6):563-9. PubMed ID: 8703663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.